By Michael Knox
09 April 2020, 2:55 PM
Morgans Chief Economist Michael Knox, discusses how 2020 will be tough, 2021 and 2022 will be boom years.
Read more...
By Nathan Lead
09 April 2020, 11:50 AM
Sydney Airport (ASX:SYD) may undertake a capital raising like Auckland Airport (ASX:AIA), as well as interesting insights from a briefing by Melbourne Airport.
Read more...
By Ivor Ries
09 April 2020, 11:20 AM
"I'm still happy to own both companies long term, and when the crisis is over, these stocks should run as hard if not harder than the market in general."
Read more...
By Andrew Tang
06 April 2020, 5:00 PM
The ~c27% correction has finally unearthed some value, and we think long term investors will be rewarded for holding their nerve through current uncertainty. Given the market moves, we make sweeping changes this month.
Read more...
By Nathan Lead
02 April 2020, 1:45 PM
COVID-19 has significantly impacted traffic on TCL’s roads. We assume a full recovery does not occur until CY22.
Read more...
By Raymond Chan
24 April 2020, 12:00 AM
新冠肺炎疫苗真可快將面世？
世界各地法寶盡出，奮力對抗新型冠狀病毒肺炎這個共同「敵人」，可惜迄今為止只能拖慢疫情擴散的速度，顯得治標不治本。其實，大家都明白到，若要成功戰勝新冠肺炎，唯一最有效的方法就是成功研發出疫苗。
很大程度上要感謝中國，在疫情初期就分享了新冠肺炎病毒的基因排序，目前已經有至少60種候選新冠肺炎疫苗，正在經由多間藥廠、生物科技公司和研究機構進行試驗
抗疫最強「武器」 臨床試驗階段
目前為止，美國生物科技公司 Moderna Therapeutics 所研發的疫苗 mRNA-1273，是最讓各方人士期盼的抗疫最強「武器」。此疫苗已經在美國華盛頓州進行臨床試驗，用於此次疫情中的高危群體，例如是前線醫護人員
澳洲的科研人員也不甘後人，現正加快進行大規模的人體測試，觀察過去幾十年以來一直用於治療肺結核病的現成疫苗，能否有效地保護前線醫護人員免受新冠肺炎感染。臨床測試中的新冠肺炎疫苗 Bacillus Calmette-Guerin（簡稱BCG），將會用於分布在澳洲全國各地的4,000位醫院前線醫護人員，務求從中了解此疫苗能否有效地紓緩新冠肺炎的病徵
BCG疫苗原本是用於對付...
Read more...